The Superiority Risk: De Minimis

• First applications are therapeutic i.e., per se non-superior

• • Although enhancement can be closeted
  • From ED to CD

• Cognitive neurotech would be PC-like

• • Available to all
  • Chance of species differentiation seems one-in-a-million